RxDoctor Payments Data

Stephen Cullen, PA

Physician Assistant · Lincoln, RINPI 1679838387

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.8% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 32.6% of the total. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,597in general payments, 2019–2025

Across 145 payments — averaging $24.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$848
  • Regeneron Healthcare Solutions, Inc.$330
  • E.r. Squibb & Sons, L.L.C.$301
  • Sanofi$179
  • Incyte Corporation$170
  • plus $596 from 9 others

What the payments were for

  • Food & beverage$3,30392%
  • Education$2948%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,597 in reported general payments places this provider in the 90th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$258,040
Medicare patients
735
Services billed
5,500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate85$5,940
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc89$4,585
Ketoconazole246$4,474
Metronidazole81$4,073
Fluocinonide92$3,301
Triamcinolone Acetonide304$2,944
Calcipotriene11$1,522
Betamethasone Dipropionate25$1,109
Fluorouracil16$1,071
Imiquimod28$1,061
Econazole Nitrate11$799
Clindamycin Phosphate23$763
Mupirocin79$590
Doxycycline Hyclate38$355
Hydrocortisone81$239

Paid to pharmacies, not to this prescriber.

Other physician assistant in Lincoln

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →